GE May Sell Spacelabs to Meet Concerns of European Regulators
|
By HospiMedica staff writers Posted on 31 Jul 2003 |
In order to get regulatory approval from the European Commission (EC) for its proposed US$2.3 billion acquisition of Instrumentarium (Helsinki, Finland), GE Medical Systems (Waukesha, WI, USA) is rumored to be considering the sale of Spacelabs (Bothell, WA, USA), a division of Instrumentarium.
Spacelabs was acquired by Instrumentarium in July 2002. The company makes and markets products for emergency and critical care, including monitoring and anesthesia equipment, as well as perioperative, neonatal, and obstetrical products. In 2002, the company had total revenues of $242 million.
GE is a major global supplier of medical imaging systems. The company's 2001 sales were $8 billion. By 2005, GE is aiming for sales to grow to about $15 million.
The European Commission has voiced its concerns that once combined, GE and Instrumentarium would have a large share of patient monitoring devices and imaging equipment used in hospitals and might be able to squeeze out smaller suppliers. The deadline for any proposals from GE is in mid-August. US regulators have not yet approved the deal, either.
Related Links:
Instrumentarium
GE Medical Systems
Spacelabs
Spacelabs was acquired by Instrumentarium in July 2002. The company makes and markets products for emergency and critical care, including monitoring and anesthesia equipment, as well as perioperative, neonatal, and obstetrical products. In 2002, the company had total revenues of $242 million.
GE is a major global supplier of medical imaging systems. The company's 2001 sales were $8 billion. By 2005, GE is aiming for sales to grow to about $15 million.
The European Commission has voiced its concerns that once combined, GE and Instrumentarium would have a large share of patient monitoring devices and imaging equipment used in hospitals and might be able to squeeze out smaller suppliers. The deadline for any proposals from GE is in mid-August. US regulators have not yet approved the deal, either.
Related Links:
Instrumentarium
GE Medical Systems
Spacelabs
Latest Business News
- World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition
- Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
- Robotic Single-Port System Gains CE Mark for Transvaginal Gynecologic Procedures
- Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award
- Partnership Advances AI Tool for Predicting Malignant Cerebral Edema
- First U.S. Commercial Cases Demonstrate New Approach to Transseptal Access
- Philips and Imricor Collaboration Advances MRI-Guided Cardiac Procedures
- FDA Approval Clears Path for BCI Integration with Personal Computing Devices
- Abbott LAA Occluder Gains CE Mark for AFib Stroke Risk Reduction
- Smart Hospital Market Set for Strong Growth as Digital Healthcare Adoption Accelerates
- FDA Seeks Feedback on Regulating Generative AI Medical Devices
- Teledyne to Acquire Varex Imaging in $1.1 Billion Deal
- MIMEDX to Add Sanara MedTech’s Regenerative Technologies Through $350 Million Deal
- AI Software Combines Nodule Detection and Diagnosis for Lung Cancer Screening
- AI Care Platform Adds Quantitative MRI Analysis for Multiple Sclerosis
- Danaher Completes Acquisition of Masimo to Expand Patient Monitoring Capabilities
Channels
Artificial Intelligence
view channel
AI Model Predicts Prolonged Sitting in Chronic Pelvic Pain
Chronic pelvic pain affects an estimated one in seven women and can occur with conditions such as endometriosis, adenomyosis, or uterine fibroids. Pain, fatigue, and other symptoms may contribute to prolonged... Read more
Autonomous AI Helps Streamline Urgent Skin Cancer Referrals
Urgent suspected skin cancer referrals place substantial pressure on dermatology services. In England, referrals have almost tripled since 2009, yet only about 6% lead to an urgent skin cancer diagnosis.... Read moreCritical Care
view channel
AI Tool Combining ECG and Blood Tests Reduces Unnecessary Heart Transplant Biopsies
Cardiac transplant rejection occurs when a recipient’s immune system attacks a donated heart. Diagnosis currently relies on biopsy, an invasive procedure in which heart muscle tissue is removed and examined... Read more
Deep Brain Stimulation Window May Matter for Parkinson’s Patients With GBA1 Variants
Patients with GBA1 gene variants may develop significant physical symptoms earlier in life while also facing greater vulnerability to cognitive problems. This combination can complicate decisions about... Read moreFDA-Approved App Enables Pulmonary Pressure Monitoring and Medication Guidance in Heart Failure
Heart failure is a chronic, progressive condition and a leading cause of hospitalization, with clinical status often deteriorating before symptoms appear. Rising pulmonary artery pressure can precede decompensation... Read moreSurgical Techniques
view channel
Matrix-Based Skin Substitute Improves Closure of Diabetic Foot Ulcers
Diabetic foot ulcers are hard-to-heal wounds that can persist because of chronic inflammation and moisture imbalance. When standard care alone does not achieve timely closure, clinicians may use adjunctive... Read more
New FDA-Approved Pediatric Pulmonary Valve Can Expand as Children Grow
Congenital pulmonary valve disease affects the valve that directs blood from the heart to the lungs. Even after repair, some children develop valve leakage that can strain and enlarge the right side of the heart.... Read morePatient Care
view channel
At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
High blood pressure is a major risk factor for cardiovascular disease, including heart attack and stroke. Many patients receiving treatment for hypertension still remain above recommended blood pressure... Read more
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read moreMedical Imaging
view channel
AI Software Detects Osteoporosis from Routine CT Scans
Osteoporosis can progress for years without pain, leaving bone loss undetected until a fracture or back pain prompts testing. By that point, bone loss may already be advanced. Bone density testing is not... Read more
AI Model Uses Pretreatment CT Scans to Predict Immunotherapy-Related Pneumonitis Risk
Pneumonitis is a potentially life-threatening form of lung inflammation that affects about 10% of patients with lung cancer receiving immunotherapy. Because it can be difficult to predict before symptoms... Read moreHealth IT
view channel
Adaptive Radiation QA Software Gains Validation for NeoArc Treatments
Adaptive radiation therapy allows clinicians to adjust treatment plans to daily anatomical changes such as tumor shrinkage, weight loss, or organ movement, improving precision while limiting exposure to... Read more
Healthcare Database Helps Close Long COVID Surveillance Gap
Long COVID is a chronic condition that occurs after SARS-CoV-2 infection and lasts at least three months. It can follow severe illness, but it can also affect anyone who has been infected.... Read morePoint of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more







